| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 73 |
| 1 | ASPIRIN 325 MG | 69 |
| 2 | ASPIRIN 81 MG | 69 |
| 3 | RIVAROXABAN | 65 |
| 4 | PREDNISOLONE | 58 |
| 5 | PREDNISOLONE ORAL | 58 |
| 6 | PREDNISOLONE ORAL SOLUTION | 58 |
| 7 | FUROSEMIDE | 43 |
| 8 | ADALIMUMAB | 41 |
| 9 | APIXABAN | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BIVALIRUDIN | 4 | 0.0040 |
| 1 | ATENOLOL AND CHLORTHALIDONE | 3 | 0.0039 |
| 2 | IDARUCIZUMAB | 5 | 0.0035 |
| 3 | BACILLUS CALMETTE-GUERIN | 4 | 0.0022 |
| 4 | EDARAVONE | 2 | 0.0012 |
| 5 | DIPYRIDAMOLE | 3 | 0.0008 |
| 6 | ALTEPLASE | 12 | 0.0008 |
| 7 | BASILIXIMAB | 9 | 0.0008 |
| 8 | CEVIMELINE HYDROCHLORIDE | 2 | 0.0007 |
| 9 | ETELCALCETIDE | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 111 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 104 |
| 2 | Factor Xa Inhibitor [EPC] | 103 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 73 |
| 4 | Loop Diuretic [EPC] | 46 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 45 |
| 6 | Proton Pump Inhibitor [EPC] | 44 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 37 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 5 | 0.0035 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 4 | 0.0022 |
| 2 | Anti-coagulant [EPC] | 5 | 0.0013 |
| 3 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 5 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Factor Xa Inhibitor [EPC] | 103 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |